📈 Economy · Next Week

Bristol-Myers Squibb (NYSE: BMY) beats Q2 2026 adjusted Non-GAAP EPS consensus of approx. $1.65 per share (July 30, 2026; confirmed by BMS press release)

Hit ✦ AI-generated prediction Published on 27. July 2026 · Predicted for 30. July 2026 · Based on: Historical Cycle

Probability

60%

BMS reports on July 30, 2026. Non-GAAP EPS consensus estimated at approximately $1.65 (extrapolated from Q1 2026 result and core product growth trajectory: Eliquis, Opdivo, Breyanzi). BMS has beaten EPS consensus for four consecutive quarters. Growing oncology pipeline (Opdualag, Camzyos, Breyanzi) offsets the fading Revlimid exclusivity tailwind. No Polymarket market; own estimate 60% (discount applied for consensus uncertainty).

Data basis for this prediction

BMS Q2 2026 Earnings Date: 30. Juli 2026 (BMS Investor Relations, 27.07.2026)
BMS: 4 aufeinanderfolgende EPS-Beats (Referenzwert Analystenberichte)
Breyanzi Q1 2026 Umsatz: stark wachsendes CAR-T-Segment (BMS IR)

Note: This is an AI-generated statistical forecast for entertainment and information purposes. It does not constitute investment advice or a recommendation to buy or sell any financial instrument.

Verdict: Hit

BMS meldete am 30. Juli 2026 einen Non-GAAP-EPS von 2,04 USD – weit über dem Konsens von ca. 1,59–1,61 USD (und damit erst recht über der in der Vorhersage angenommenen Konsensschätzung von ~1,65 USD). Das entspricht einem Beat von rund +0,43 USD bzw. ~27 %. Treiber waren das Wachstumsportfolio (+14 % ex-FX auf 7,6 Mrd. USD), insbesondere Eliquis und Opdivo. Der Jahresausblick für Non-GAAP-EPS wurde daraufhin von 6,05–6,35 USD auf 6,75–7,00 USD angehoben. Quellen: BMS-Pressemitteilung (news.bms.com), Investing.com, Yahoo Finance/Zacks.

Related Predictions

📈 Economy ✦ AI

S&P 500 (SPX) closes above 7,500 on Friday, 13 November 2026 (confirmed via NYSE closing price or Bloomberg by 14 November 2026, 10:00 ET)

The S&P 500 dropped 4.36% on 5 November 2026 to 7,353.73 — its steepest one-day fall since April 2025 — triggered by an AI-chip selloff that wiped out the post-midterm rally (4 November: +1.72% to 7,698.80). Closing above 7,500 by 13 November requires a +2.0% recovery over 6 trading sessions. Goldman Sachs, Morgan Stanley and JPMorgan maintain year-end targets of 7,400–8,100; S&P 500 EPS growth consensus for 2026 stands at +14% YoY. Downside risks: elevated Treasury yields, persistent AI capex uncertainty. No specific Polymarket/Kalshi market found for this level.

62%

Next Week · Predicted for 13. Nov 2026

📈 Economy ✦ AI

US Consumer Price Index (headline CPI) for October 2026 exceeds 3.7 percent year-on-year — BLS release November 10, 2026, 8:30 AM ET (confirmed by BLS or Bloomberg by November 10, 2026, 10:00 AM ET)

The BLS releases October 2026 CPI on November 10, 2026 at 8:30 AM ET. Nowflation forecasts 3.82 percent YoY; the Cleveland Fed nowcasting model forecasts 3.74 percent — both clearly above the 3.7 percent threshold. The September 2026 prior reading was exactly 3.7 percent. Rising energy prices (Strait of Hormuz effectively closed since mid-October) and stable core inflation support a further uptick. An existing open platform prediction covers CPI >3.5%; this forecast raises the bar by 20 basis points. A miss would primarily require unexpected weakness in the energy component or food prices.

65%

Next Week · Predicted for 10. Nov 2026

📈 Economy ✦ AI

Gold (XAU/USD Spot) closes above $4,400 per ounce on 31 December 2026 (confirmed by Bloomberg or Kitco by 1 January 2027)

Gold (XAU/USD) rose to $4,134.83 on 5 November 2026 — driven by the Democratic midterm sweep (higher fiscal spending expected) and persistent inflation pressure. Kalshi's Dec 31 settlement market shows ~32% probability for a close above $4,400 and ~43% for above $4,300. Reaching the $4,400 year-end target would require a further ~6.4% gain. Supporting factors: fiscal expansion, geopolitical risks, structurally high central bank demand; UBS forecasts $4,800, JPMorgan $6,000 at year-end. Headwind: hawkish Fed stance (Polymarket: 72.5% for a December rate hike to 4.00–4.25%). Prediction anchors on Kalshi's ~32% for >$4,400.

32%

Next Year · Predicted for 31. Dec 2026